Xtent’s CUSTOM II trial
This article was originally published in The Gray Sheet
Executive Summary
Delivery of longest stent ever with a single catheter achieved in first stages of Xtent's 70-patient feasibility trial examining the use of the firm's Biolimus A9-eluting stent to treat long-lesion, multi-lesion and multi-vessel disease. The firm also noted that physicians in the study used a single catheter to treat multiple lesions in multiple arteries, a first in coronary stenting. The firm believes that its ability to treat long lesions will differentiate it from the competition (1"The Gray Sheet" Oct. 24, 2005, p. 21)...